
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $267.6M | $443.3M | $660.1M | $829.3M | $1B | |
Revenue Growth (YoY) | 36.53% | 65.67% | 48.91% | 25.62% | 22.44% | |
Cost of Revenues | $43.4M | $81.4M | $139.3M | $192.4M | $159.4M | |
Gross Profit | $224.2M | $361.9M | $520.8M | $636.9M | $855.9M | |
Gross Profit Margin | 83.79% | 81.64% | 78.9% | 76.8% | 84.3% | |
R&D Expenses | $34.2M | $35.7M | $66.6M | $76.4M | $79M | |
Selling, General & Admin | $45.7M | $50.3M | $143.5M | $149.2M | $154.3M | |
Other Inc / (Exp) | $5.4M | -$19.9M | -$1.7M | $29.5M | $23.8M | |
Operating Expenses | $80M | $86M | $253.3M | $299.3M | $304.4M | |
Operating Income | $144.3M | $275.9M | $267.5M | $337.6M | $551.5M | |
Net Interest Expenses | $20.4M | $7.5M | $16.9M | $18.8M | $18.1M | |
EBT. Incl. Unusual Items | $129.3M | $248.5M | $248.9M | $348.3M | $557.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $217K | -$154.2M | $46.8M | $66.7M | $113M | |
Net Income to Company | $129.1M | $402.7M | $202.1M | $281.6M | $444.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $129.1M | $402.7M | $202.1M | $281.6M | $444.1M | |
Basic EPS (Cont. Ops) | $0.95 | $2.86 | $1.48 | $2.13 | $3.50 | |
Diluted EPS (Cont. Ops) | $0.91 | $2.74 | $1.44 | $2.10 | $3.43 | |
Weighted Average Basic Share | $136.2M | $140.6M | $136.8M | $131.9M | $126.8M | |
Weighted Average Diluted Share | $141.5M | $146.8M | $140.6M | $134.2M | $129.4M | |
EBITDA | $153M | $259M | $315.5M | $451.9M | $656.5M | |
EBIT | $149.7M | $256M | $265.9M | $367.1M | $575.2M | |
Revenue (Reported) | $267.6M | $443.3M | $660.1M | $829.3M | $1B | |
Operating Income (Reported) | $144.3M | $275.9M | $267.5M | $337.6M | $551.5M | |
Operating Income (Adjusted) | $149.7M | $256M | $265.9M | $367.1M | $575.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $89M | $117.3M | $162.1M | $195.9M | $264.9M | |
Revenue Growth (YoY) | 251.12% | 31.74% | 38.25% | 20.81% | 35.22% | |
Cost of Revenues | $18.2M | $15.9M | $35.2M | $28.3M | $48.4M | |
Gross Profit | $70.8M | $101.4M | $127M | $167.6M | $216.5M | |
Gross Profit Margin | 79.53% | 86.42% | 78.31% | 85.54% | 81.73% | |
R&D Expenses | $9M | $11.9M | $18M | $19.1M | $14.8M | |
Selling, General & Admin | $11.1M | $13.8M | $37.4M | $35.1M | $42.4M | |
Other Inc / (Exp) | -$20.7M | $498K | $3M | $5M | $6.8M | |
Operating Expenses | $20.1M | $25.7M | $73.2M | $72M | $74.9M | |
Operating Income | $50.7M | $75.7M | $53.8M | $95.5M | $141.5M | |
Net Interest Expenses | $2M | $1.8M | $4.5M | $4.5M | $4.5M | |
EBT. Incl. Unusual Items | $28.1M | $74.4M | $52.2M | $96M | $143.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $191K | $14.3M | $12.6M | $19.2M | $25.7M | |
Net Income to Company | $27.9M | $60.1M | $39.6M | $76.8M | $118.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $27.9M | $60.1M | $39.6M | $76.8M | $118.1M | |
Basic EPS (Cont. Ops) | $0.20 | $0.44 | $0.29 | $0.61 | $0.96 | |
Diluted EPS (Cont. Ops) | $0.19 | $0.43 | $0.29 | $0.60 | $0.93 | |
Weighted Average Basic Share | $138M | $137.7M | $135M | $126.9M | $123.2M | |
Weighted Average Diluted Share | $148.5M | $141.3M | $137.9M | $128.9M | $126.6M | |
EBITDA | $30.8M | $76.9M | $77.2M | $120.7M | $168.8M | |
EBIT | $30.1M | $76.2M | $56.8M | $100.5M | $148.4M | |
Revenue (Reported) | $89M | $117.3M | $162.1M | $195.9M | $264.9M | |
Operating Income (Reported) | $50.7M | $75.7M | $53.8M | $95.5M | $141.5M | |
Operating Income (Adjusted) | $30.1M | $76.2M | $56.8M | $100.5M | $148.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $331.3M | $471.6M | $705M | $863M | $1.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $55.8M | $79.1M | $158.6M | $185.5M | $179.5M | |
Gross Profit | $275.5M | $392.5M | $546.4M | $677.5M | $904.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $33.1M | $38.5M | $72.7M | $77.5M | $74.7M | |
Selling, General & Admin | $44.2M | $53.1M | $167M | $147M | $161.6M | |
Other Inc / (Exp) | -$17.7M | $1.3M | $815K | $31.5M | $25.6M | |
Operating Expenses | $77.3M | $91.6M | $300.8M | $298.2M | $307.3M | |
Operating Income | $198.2M | $300.8M | $245.7M | $379.3M | $597.5M | |
Net Interest Expenses | $17M | $7.3M | $19.7M | $18.7M | $18.1M | |
EBT. Incl. Unusual Items | $163.5M | $294.8M | $226.7M | $392.1M | $604.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $397K | -$140.1M | $45.1M | $73.3M | $119.6M | |
Net Income to Company | $163.1M | $434.9M | $181.6M | $318.8M | $485.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $163.1M | $434.9M | $181.6M | $318.8M | $485.4M | |
Basic EPS (Cont. Ops) | $1.20 | $3.09 | $1.33 | $2.45 | $3.85 | |
Diluted EPS (Cont. Ops) | $1.13 | $2.99 | $1.31 | $2.42 | $3.76 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $183.6M | $305.2M | $315.8M | $495.5M | $704.6M | |
EBIT | $180.5M | $302.2M | $246.5M | $410.8M | $623M | |
Revenue (Reported) | $331.3M | $471.6M | $705M | $863M | $1.1B | |
Operating Income (Reported) | $198.2M | $300.8M | $245.7M | $379.3M | $597.5M | |
Operating Income (Adjusted) | $180.5M | $302.2M | $246.5M | $410.8M | $623M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $89M | $117.3M | $162.1M | $195.9M | $264.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $18.2M | $15.9M | $35.2M | $28.3M | $48.4M | |
Gross Profit | $70.8M | $101.4M | $127M | $167.6M | $216.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $9M | $11.9M | $18M | $19.1M | $14.8M | |
Selling, General & Admin | $11.1M | $13.8M | $37.4M | $35.1M | $42.4M | |
Other Inc / (Exp) | -$20.7M | $498K | $3M | $5M | $6.8M | |
Operating Expenses | $20.1M | $25.7M | $73.2M | $72M | $74.9M | |
Operating Income | $50.7M | $75.7M | $53.8M | $95.5M | $141.5M | |
Net Interest Expenses | $2M | $1.8M | $4.5M | $4.5M | $4.5M | |
EBT. Incl. Unusual Items | $28.1M | $74.4M | $52.2M | $96M | $143.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $191K | $14.3M | $12.6M | $19.2M | $25.7M | |
Net Income to Company | $27.9M | $60.1M | $39.6M | $76.8M | $118.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $27.9M | $60.1M | $39.6M | $76.8M | $118.1M | |
Basic EPS (Cont. Ops) | $0.20 | $0.44 | $0.29 | $0.61 | $0.96 | |
Diluted EPS (Cont. Ops) | $0.19 | $0.43 | $0.29 | $0.60 | $0.93 | |
Weighted Average Basic Share | $138M | $137.7M | $135M | $126.9M | $123.2M | |
Weighted Average Diluted Share | $148.5M | $141.3M | $137.9M | $128.9M | $126.6M | |
EBITDA | $30.8M | $76.9M | $77.2M | $120.7M | $168.8M | |
EBIT | $30.1M | $76.2M | $56.8M | $100.5M | $148.4M | |
Revenue (Reported) | $89M | $117.3M | $162.1M | $195.9M | $264.9M | |
Operating Income (Reported) | $50.7M | $75.7M | $53.8M | $95.5M | $141.5M | |
Operating Income (Adjusted) | $30.1M | $76.2M | $56.8M | $100.5M | $148.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $147.7M | $118.7M | $234.2M | $118.4M | $115.9M | |
Short Term Investments | $220.3M | $622.2M | $128.6M | $217.6M | $480.2M | |
Accounts Receivable, Net | $98.7M | $92.1M | $188.9M | $240M | $296.9M | |
Inventory | $60.7M | $53.9M | $100.1M | $127.6M | $141.9M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $28.3M | $40.5M | $45M | $48.6M | $39M | |
Total Current Assets | $554.8M | $926.3M | $739M | $746.4M | $1.1B | |
Property Plant And Equipment | $10.6M | $8.8M | $75.6M | $74.9M | $75M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | $409M | $416.8M | $416.8M | |
Other Intangibles | -- | -- | $546.7M | $472.9M | $401.8M | |
Other Long-Term Assets | $14.6M | $13.9M | $26.8M | $17.8M | $80.6M | |
Total Assets | $579.9M | $1.1B | $1.8B | $1.7B | $2.1B | |
Accounts Payable | $1.9M | $1.5M | $17.7M | $11.8M | $10.2M | |
Accrued Expenses | $20.5M | $24.4M | $99.8M | $100.7M | $128.9M | |
Current Portion Of Long-Term Debt | -- | $89.4M | $13.3M | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $421.4M | $117.1M | $130.8M | $112.5M | $139.1M | |
Long-Term Debt | -- | $787.3M | $1.5B | $1.5B | $1.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $428.9M | $907.5M | $1.7B | $1.6B | $1.7B | |
Common Stock | $135K | $138K | $135K | $127K | $123K | |
Other Common Equity Adj | $22K | -$620K | -$922K | -$9.3M | $3.8M | |
Common Equity | $151M | $197M | $169.8M | $83.8M | $363.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $151M | $197M | $169.8M | $83.8M | $363.8M | |
Total Liabilities and Equity | $579.9M | $1.1B | $1.8B | $1.7B | $2.1B | |
Cash and Short Terms | $368M | $740.9M | $362.8M | $336M | $596.1M | |
Total Debt | $397.2M | $876.7M | $1.5B | $1.5B | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $499.5M | $117.8M | $96.4M | $164.6M | $176.3M | |
Short Term Investments | $264.9M | $668.3M | $179.2M | $298.8M | $571.6M | |
Accounts Receivable, Net | $89.5M | $115M | $200.8M | $191.5M | $311M | |
Inventory | $58.3M | $47.8M | $107.5M | $168.5M | $164.9M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $30.7M | $41M | $37M | $45.7M | $44.6M | |
Total Current Assets | $941.7M | $988.7M | $615M | $873.6M | $1.3B | |
Property Plant And Equipment | $10.4M | $8.5M | $78M | $78.1M | $72.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | $416.2M | $416.8M | $416.8M | |
Other Intangibles | -- | -- | $528.8M | $455.1M | $384.1M | |
Other Long-Term Assets | $14.5M | $22.5M | $25.7M | $17.3M | $55.6M | |
Total Assets | $966.6M | $1.2B | $1.7B | $1.8B | $2.2B | |
Accounts Payable | $535K | $1.3M | $8.7M | $13.3M | $20.1M | |
Accrued Expenses | $16.1M | $19.1M | $80M | $118.3M | $130.3M | |
Current Portion Of Long-Term Debt | -- | $89.5M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $107.4M | $111.7M | $91.9M | $131.6M | $150.4M | |
Long-Term Debt | $784.7M | $788.1M | $1.5B | $1.5B | $1.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $899M | $902M | $1.6B | $1.7B | $1.7B | |
Common Stock | $143K | $138K | $132K | $127K | $123K | |
Other Common Equity Adj | -$9K | -$2.8M | $24K | -$1.5M | -$3.4M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $67.6M | $260.3M | $65.9M | $177.8M | $482.3M | |
Total Liabilities and Equity | $966.6M | $1.2B | $1.7B | $1.8B | $2.2B | |
Cash and Short Terms | $764.3M | $786.1M | $275.6M | $463.5M | $747.9M | |
Total Debt | $873.8M | $877.6M | $1.5B | $1.5B | $1.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $129.1M | $402.7M | $202.1M | $281.6M | $444.1M | |
Depreciation & Amoritzation | $3.3M | $3M | $49.6M | $84.9M | $81.3M | |
Stock-Based Compensation | $17.2M | $20.8M | $24.4M | $36.6M | $43.4M | |
Change in Accounts Receivable | -$38.3M | $6.8M | -$83.9M | -$3.3M | -$74.2M | |
Change in Inventories | -$31.4M | $7.4M | -$17.5M | -$26.9M | -$67.4M | |
Cash From Operations | $55.5M | $299.4M | $240.1M | $388.6M | $479.1M | |
Capital Expenditures | $2.5M | $1.5M | $4.8M | $15.3M | $10.7M | |
Cash Acquisitions | -- | -- | -$999.1M | -- | -- | |
Cash From Investing | $78.4M | -$406.3M | -$487M | -$96.9M | -$262.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $784.9M | $1.1B | -- | -- | |
Long-Term Debt Repaid | -$19.6M | -$369.1M | -$447.5M | -$13.5M | -- | |
Repurchase of Common Stock | -$150.1M | -$350.1M | -$200M | -$402.4M | -$250M | |
Other Financing Activities | -- | -$424K | -$76.2M | -- | -- | |
Cash From Financing | -$106.3M | $77.9M | $362.4M | -$408M | -$218.9M | |
Beginning Cash (CF) | $120.7M | $148.2M | $119.2M | $234.7M | $118.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $27.5M | -$29M | $115.5M | -$116.3M | -$2.5M | |
Ending Cash (CF) | $148.2M | $119.2M | $234.7M | $118.4M | $115.9M | |
Levered Free Cash Flow | $53M | $298M | $235.3M | $373.3M | $468.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $27.9M | $60.1M | $39.6M | $76.8M | $118.1M | |
Depreciation & Amoritzation | $738K | $778K | $20.5M | $20.2M | $20.4M | |
Stock-Based Compensation | $4.9M | $4.7M | $8M | $9.9M | $10.7M | |
Change in Accounts Receivable | $9.3M | -$22.8M | $36.2M | $38.3M | $3.8M | |
Change in Inventories | $2.5M | $6.3M | -$7.3M | -$40.2M | -$586K | |
Cash From Operations | $58.3M | $47.8M | $87M | $129.4M | $154.2M | |
Capital Expenditures | $270K | $490K | $11.4M | $3.5M | $950K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$45.3M | -$49.3M | -$60.2M | -$82.7M | -$90.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $784.9M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$369.1M | -- | -$13.5M | -- | -- | |
Repurchase of Common Stock | -$76.2M | -- | -$150.1M | -- | -- | |
Other Financing Activities | -$329K | -- | -- | -- | -- | |
Cash From Financing | $338.7M | $624K | -$164.6M | -$489K | -$3.3M | |
Beginning Cash (CF) | $148.2M | $119.2M | $234.7M | $118.4M | $115.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $351.7M | -$884K | -$137.8M | $46.3M | $60.5M | |
Ending Cash (CF) | $500M | $118.3M | $96.9M | $164.6M | $176.3M | |
Levered Free Cash Flow | $58M | $47.3M | $75.6M | $125.9M | $153.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $163.1M | $434.9M | $181.6M | $318.8M | $485.4M | |
Depreciation & Amoritzation | $3.2M | $3M | $69.3M | $84.6M | $81.6M | |
Stock-Based Compensation | $17.6M | $20.6M | $27.6M | $38.5M | $44.2M | |
Change in Accounts Receivable | -$58.6M | -$25.4M | -$25M | -$1.2M | -$108.7M | |
Change in Inventories | -$16.8M | $11.2M | -$31M | -$59.9M | -$27.7M | |
Cash From Operations | $118.6M | $288.9M | $279.3M | $431M | $503.9M | |
Capital Expenditures | $2.7M | $1.7M | $15.7M | $7.5M | $8.1M | |
Cash Acquisitions | -- | -- | -$999.1M | -- | -- | |
Cash From Investing | -$5M | -$410.3M | -$497.9M | -$119.4M | -$270.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $784.9M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$371.9M | -- | -$460.9M | -- | -- | |
Repurchase of Common Stock | -$174.7M | -$273.9M | -$350.1M | -$252.3M | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $281M | -$260.2M | $197.1M | -$243.9M | -$221.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $394.6M | -$381.6M | -$21.5M | $67.7M | $11.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $115.9M | $287.3M | $263.6M | $423.6M | $495.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $27.9M | $60.1M | $39.6M | $76.8M | $118.1M | |
Depreciation & Amoritzation | $738K | $778K | $20.5M | $20.2M | $20.4M | |
Stock-Based Compensation | $4.9M | $4.7M | $8M | $9.9M | $10.7M | |
Change in Accounts Receivable | $9.3M | -$22.8M | $36.2M | $38.3M | $3.8M | |
Change in Inventories | $2.5M | $6.3M | -$7.3M | -$40.2M | -$586K | |
Cash From Operations | $58.3M | $47.8M | $87M | $129.4M | $154.2M | |
Capital Expenditures | $270K | $490K | $11.4M | $3.5M | $950K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$45.3M | -$49.3M | -$60.2M | -$82.7M | -$90.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $784.9M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$369.1M | -- | -$13.5M | -- | -- | |
Repurchase of Common Stock | -$76.2M | -- | -$150.1M | -- | -- | |
Other Financing Activities | -$329K | -- | -- | -- | -- | |
Cash From Financing | $338.7M | $624K | -$164.6M | -$489K | -$3.3M | |
Beginning Cash (CF) | $148.2M | $119.2M | $234.7M | $118.4M | $115.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $351.7M | -$884K | -$137.8M | $46.3M | $60.5M | |
Ending Cash (CF) | $500M | $118.3M | $96.9M | $164.6M | $176.3M | |
Levered Free Cash Flow | $58M | $47.3M | $75.6M | $125.9M | $153.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.